EDETEK Launches “Ensemble” AI Managed Services to Simplify Adoption of AI and Accelerate Clinical Development 
The Future of Wellness in an AI World
AI Is Redefining Consumer Expectations, Even in the Nutraceutical Sector. Brand Strategies Should Adjust, Too. FORT LAUDERDALE, Fla., June 2,...
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
News Summary Up to six-fold increase in performance robustness with StepWave™ XR Ion Guide versus Xevo TQ Absolute.1Uses up to...
Tecsys Introduces ESL+, an Interactive Shelf Labeling Solution for Hospital Inventory Management
Next-generation digital label brings clinical-first visibility, automation and feedback loop to the point of use hospital supply chain. NASHVILLE, Tenn.,...
Curogen Taps Industry Veteran Arvind Sood to Establish and Grow U.S. Business; Expands Global Board of Directors
SEOUL, South Korea and BEVERLY HILLS, Calif., June 2, 2025 /PRNewswire/ -- Curogen, one of South Korea's leading biotechnology companies...
Sapience Therapeutics Provides Data Update from Phase 2 Trial of Lucicebtide in Patients with Glioblastoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
-Clinical benefit and favorable safety profile as monotherapy and in combination with SOC- -Biomarker data supports MOA: decreased GBM mesenchymal...
RaySearch to present advanced software innovations for particle therapy at PTCOG 63
STOCKHOLM, June 2, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) will exhibit at PTCOG 63, held June 3-6, 2025, in...
Maxwell Healthcare Associates Announces Rebrand to Maxwell TEC
SHOREVIEW, Minn., June 2, 2025 /PRNewswire/ -- Maxwell Healthcare Associates (MHA) announced today its rebrand to Maxwell TEC, signaling a...
Rapid Dose Announces Completion of Share Issuance in Debt Settlement with Creditors
Burlington, Ontario--(Newsfile Corp. - June 2, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced...
Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality
This major Swoop® system scanner redesign and Optive AI™ software elevate the AI-powered portable MRI experience for clinicians and their...
Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality
This major Swoop® system scanner redesign and Optive AI™ software elevate the AI-powered portable MRI experience for clinicians and their...
Evosep unveils new instrumentation and partnership at ASMS 2025
Evosep Eno The new Evosep Eno from Evosep will set the stage for next generation LC-MS based proteomics BALTIMORE, Md.,...
Solera Health Unveils Enhanced AI Governance Framework for Responsible and Transparent Use of Artificial Intelligence in Digital Health
Framework Sets an Industry Benchmark for Client Trust and Ethical AI Use to Ensure Patient Safety and AccountabilityPHOENIX, June 02,...
Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed/Refractory Multiple Myeloma
TRIgnite-1 study shows an overall response rate (ORR) of 74% across nine dose levels, in heavily pretreated patients with a...
Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types
MONSTAR-SCREEN-3 study showed 100% detection of circulating tumor DNA (ctDNA) at baseline timepoint, and 60% of patients testing positive one...
Liberation Labs is Now Liberation Bioindustries
New name, new brand better reflects the company’s position as a global, commercial-scale biomanufacturer Liberation Labs Rebrands: Now Liberation Bioindustries...
PathAI and Northwestern Medicine Announce Strategic Collaboration to Deploy the AISight® Digital Pathology Platform and Co-Develop New AI Diagnostics
Collaboration includes use of PathAI’s AISight®¹ digital pathology image management system at Northwestern Medicine and joint efforts in research, clinical...
New Independent Review Paper Strengthens Therapeutic Rationale for Artelo’s FABP Inhibitor Program in Anxiety and Depression
SOLANA BEACH, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on...
Actuate Therapeutics Shares Highlights from KOL Event on Positive Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer
- Expert Insights on Clinical Relevance and Scientific Rationale- The replay of the event is available on the Investor Relations...
TerrAscend Announces Chief Financial Officer Transition Plan
TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND, OTCQX: TSNDF), a leading North...
Xilio Therapeutics Announces Pricing of $50.0 Million Public Offering
WALTHAM, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing...